nipradilol

{{Chembox

| ImageFile = Nipradilol.svg

| ImageSize = 200px

| ImageAlt =

| IUPACName = [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 81486-22-8

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = FVM336I71Y

| PubChem = 72006

| InChI=1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3

| InChIKey= OMCPLEZZPVJJIS-UHFFFAOYSA-N

| SMILES = CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O

| ChemSpiderID = 65005}}

|Section2={{Chembox Properties

| C=15 | H=22 | N=2 | O=6

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Nipradilol is a beta blocker and nitric oxide donor.{{cite journal|pmid=21966188|year=2011|last1=Inoue|first1=K|last2=Kei Noguchi|first2=K|last3=Masumoto|first3=M|last4=Wakakura|first4=G|title=Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma|volume=5|pages=1211–6|doi=10.2147/OPTH.S23233|pmc=3180485|journal=Clinical Ophthalmology |doi-access=free }}